Mereo Biopharma Group Plc(MREO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MREO Mereo Biopharma Group Plc

Market Closed 12-12 16:00:00 EST

2.17

-0.08

-3.56%

盘后2.23

+0.06+2.76%

19:30 EST

High2.31	Low2.17	Vol2.21M
Open2.21	D1 Closing2.25	Amplitude6.22%
Mkt Cap345.32M	Tradable Cap218.02M	Total Shares159.13M
T/O4.94M	T/O Rate2.20%	Tradable Shares100.47M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MREO","market":"US","secType":"STK","nameCN":"Mereo Biopharma Group Plc","latestPrice":2.17,"timestamp":1765573200000,"preClose":2.25,"halted":0,"volume":2213168,"hourTrading":{"tag":"盘后","latestPrice":2.23,"preClose":2.17,"latestTime":"19:30 EST","volume":5799,"amount":12716.6004,"timestamp":1765585834312},"delay":0,"floatShares":100470459,"shares":159131700,"eps":-0.26286,"marketStatus":"Market Closed","change":-0.08,"latestTime":"12-12 16:00:00 EST","open":2.21,"high":2.31,"low":2.17,"amount":4939745.8273728,"amplitude":0.062222,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.26286,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"adrRate":5,"listingDate":1556078400000,"exchange":"NASDAQ","adjPreClose":2.25,"preHourTrading":{"tag":"盘前","latestPrice":2.25,"preClose":2.25,"latestTime":"09:28 EST","volume":6715,"amount":15374.975576,"timestamp":1765549707066},"postHourTrading":{"tag":"盘后","latestPrice":2.23,"preClose":2.17,"latestTime":"19:30 EST","volume":5799,"amount":12716.6004,"timestamp":1765585834312},"volumeRatio":0.9466765961595429,"impliedVol":3.6082,"impliedVolPercentile":0.948},"requestUrl":"/m/hq/s/MREO/tweets","defaultTab":"tweets","newsList":[{"id":"2588052084","title":"European Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2588052084","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588052084?lang=en_us&edition=fundamental","pubTime":"2025-12-03 00:11","pubTimestamp":1764691909,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were higher late Tuesday morning, rising 0.58% to 1,633.19 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications  and 3D printer firm Materialise , which climbed 7.4% and 2.4% respectively. They were followed by lender ING Group  and biopharmaceutical company argenx , which advanced 2.1% and 1.5% respectively.The decliners from continental Europe were led by consumer goods company Unilever  and pharmaceutical company Novo Nordisk , which fell 1.5% and 1.3% respectively. They were followed by accommodations booking company trivago  and internet advertising firm Criteo , which were off 1% and 0.9% respectively.From the UK and Ireland, the gainers were led by pharmaceutical company GSK  and telecommunications operator Vodafone Group , which rose 2.1% and 2.0% respectively. They were followed by lender Lloyds Banking Group , which was up 1.9%.The dec","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ULVR.UK","BK7141","ING.AU","LU0320765992.SGD","MREO","SQNS","SLN","LYG","BK4077","BK4141","LU0889565916.HKD","ING","IE00BKVL7J92.USD","BK4599","GSK.UK","IE00BJJMRZ35.SGD","LU1093756325.SGD","GSK","NVO.AU","BK4132","IE00BJT1NW94.SGD","BK4546","BK4183","DAVA.AU","IE00BZ1G4Q59.USD","LU2324357040.USD","UL","BK7104","BK4521","DAVA","IE00BFMHRM44.USD","ARGX","MTLS","IE00BFTCPJ56.SGD","WPP","LU0689626769.HKD","IE00B2B36J28.USD","BK4592","BK4134","BK4139","CRTO","LU0084288595.USD","BK4532","VOD","WPP.AU","BK4117","UN","TRVG","AFG"],"gpt_icon":1},{"id":"2588726976","title":"Viridis clears final hurdle for Brazilian rare earth licence","url":"https://stock-news.laohu8.com/highlight/detail?id=2588726976","media":"The West Australian","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588726976?lang=en_us&edition=fundamental","pubTime":"2025-12-01 10:13","pubTimestamp":1764555217,"startTime":"0","endTime":"0","summary":"Viridis Mining and Minerals confirmed today it remains on track to secure the all-important Preliminary Licence for its flagship Colossus ionic clay rare earths project in Poços de Caldas, Brazil. ","market":"us","thumbnail":"https://images.thewest.com.au/publication/C-20858582/7beb95b553b6aaf122297b5433b0328bcf75d660.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-20858582/7beb95b553b6aaf122297b5433b0328bcf75d660.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/viridis-clears-final-hurdle-for-brazilian-rare-earth-licence-c-20858582","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/viridis-clears-final-hurdle-for-brazilian-rare-earth-licence-c-20858582","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["MREO","BK4505","BK4139"],"gpt_icon":0},{"id":"2586266977","title":"European Equities Traded in the US as American Depositary Receipts Surge in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2586266977","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586266977?lang=en_us&edition=fundamental","pubTime":"2025-11-27 00:03","pubTimestamp":1764172980,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were surging higher late Wednesday morning, rising 1.25% to 1,614.11 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by pharmaceutical companies Novo Nordisk  and Ascendis Pharma , which rose 3.5% and 1.8%, respectively. They were followed by biopharmaceutical company DBV Technologies  and lender Banco Santander , which were up 1.7% and 1.6%, respectively.The decliners from continental Europe were led by biopharmaceutical company Cellectis  and brewing company Anheuser-Busch InBev , which fell 4.6% and 1%, respectively. They were followed by biotech firm Evaxion  and pharmaceutical company Sanofi , which were off 0.9% each.From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics  and NuCana , which increased 5.5% and 3.7%, respectively. They were followed by lenders Barclays  and Lloyds Banking Group , which advanced 3.2% each.The decliners from the","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4588","BK4139","BK4599","DGE.UK","LU1093756168.USD","LU0109394709.USD","NCNA","BK4158","IE00BZ1G4Q59.USD","LU0320765992.SGD","BK7104","IE00BFXG1179.USD","BK7119","BUD","SNY","BK4532","DBVT","SAN","NVO","LU0889565916.HKD","NVO.AU","AUTL","BK4007","BK4521","SAN.AU","BCYC","BK4505","IE00BKVL7J92.USD","CLLS","BCS","LYG","DEO","BUD.AU","LU0154236417.USD","MREO","BK4107","EVAX","BK4117","BK4207","BK7142","AFG","ASND","AKTX","LU1093756325.SGD","BK4559","BK4169"],"gpt_icon":1},{"id":"2586562496","title":"European Equities Traded in the US as American Depositary Receipts Little Changed in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2586562496","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586562496?lang=en_us&edition=fundamental","pubTime":"2025-11-25 00:14","pubTimestamp":1764000859,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts opened the week little changed late Monday morning, edging 0.1% higher to 1,572.55 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Cellectis  and internet browser company Opera , which advanced 10% and 2.4%, respectively. They were followed by medical device maker EDAP TMS  and telecommunications company Nokia , which increased 1.7% and 1.5%, respectively.The decliners from continental Europe were led by pharmaceutical company Novo Nordisk  and internet advertising firm Criteo , which fell 7.8% and 1.4%, respectively. They were followed by oil and gas company Eni , which was down 1%.From the UK and Ireland, the gainers were led by biopharmaceutical companies Mereo BioPharma Group  and Bicycle Therapeutics , which rose 3.6% each. They were followed by biotech firm Trinity Biotech  and biopharmaceutical company NuCana , which were up 3.2% and 1.7%, respectively","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["WPP.AU","NCNA","BK4201","BK4139","WPP","BK4532","BK4007","BK4588","BK4505","BK4599","LU1093756325.SGD","BK4547","IE00BMPRXR70.SGD","LU0154236417.USD","NVO.AU","BCYC","CRTO","OPRA","TRIB","BK4117","LU1093756168.USD","NGG","IE00BFMHRM44.USD","BDRX","BK4082","NVO","BK4023","AKTX","BK4020","CLLS","EDAP","IE00BKVL7J92.USD","BK4585","NOK","IE00BMPRXN33.USD","AFG","BK7104","EVAX","BK4009","E","MREO","BK4107","BK4208","IE00BZ1G4Q59.USD"],"gpt_icon":1},{"id":"2584921938","title":"Mereo BioPharma Q3 Net Income USD -7.024 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2584921938","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584921938?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:15","pubTimestamp":1763572542,"startTime":"0","endTime":"0","summary":"Nov 10 (Reuters) - Mereo BioPharma Q3 operating income USD -10.015 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 10-NOV-202521:01:46.177 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD1C6WrN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","MREO"],"gpt_icon":0},{"id":"2584627021","title":"European Equities Traded in the US as American Depositary Receipts Slightly Lower in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2584627021","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584627021?lang=en_us&edition=fundamental","pubTime":"2025-11-18 00:19","pubTimestamp":1763396365,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were slightly lower late Monday morning, edging 0.1% lower to 1,610.86 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Cellectis  and pharmaceutical company Ascendis Pharma , which climbed 7.5% and 7.2%, respectively. They were followed by biopharmaceutical companies DBV Technologies  and Genfit , which advanced 5.4% and 3.5%, respectively.The decliners from continental Europe were led by software firm SAP  and lender Banco Santander , which fell 1.9% each. They were followed by brewing company Anheuser-Busch InBev  and health technology company Philips , which were down 1.6% and 1.4%, respectively.From the UK and Ireland, the gainers were led by communications company WPP  and biopharmaceutical company Mereo BioPharma Group , which rose 11% and 2.5%, respectively. They were followed by biopharmaceutical company Bicycle Therapeutics  and pharmaceutical compan","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PHG","BK4023","GNFT","BK4505","BK4082","BK4588","BK4613","NCNA","GSK.UK","AKTX","SAP","BK7119","BK4107","MREO","BK4207","WPP","BK4585","BK4158","SAN","DBVT","BCYC","BUD.AU","BK7142","BK4532","BK4528","GSK","SAN.AU","TRIB","AFG","BK4139","ASND","LU0109394709.USD","BK4009","LU1829250122.USD","BDRX","LU0889565916.HKD","BK4007","WPP.AU","BK4117","LU0320765992.SGD","GNFTY","BUD","CLLS","BK4521"],"gpt_icon":0},{"id":"2584161696","title":"Fund manager plunges $500k into Critica $8m raise","url":"https://stock-news.laohu8.com/highlight/detail?id=2584161696","media":"The West Australian","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584161696?lang=en_us&edition=fundamental","pubTime":"2025-11-17 04:38","pubTimestamp":1763325496,"startTime":"0","endTime":"0","summary":"Critica Ltd has locked in a $500k commitment from specialist junior mining investor Lion Selection as part of its oversubscribed $8 million placement to accelerate its flagship Jupiter rare earths project.","market":"nz","thumbnail":"https://images.thewest.com.au/publication/C-20703408/8f418cc3ec7b47ba061a2bc646751014d96d5da4.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-20703408/8f418cc3ec7b47ba061a2bc646751014d96d5da4.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/fund-manager-plunges-500k-into-critica-8m-raise-c-20703408","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/fund-manager-plunges-500k-into-critica-8m-raise-c-20703408","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["MREO","BK4139","BK4505"],"gpt_icon":0},{"id":"2583205592","title":"European Equities Traded in the US as American Depositary Receipts Slightly Higher in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2583205592","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583205592?lang=en_us&edition=fundamental","pubTime":"2025-11-14 00:19","pubTimestamp":1763050780,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were slightly higher late Thursday morning, rising 0.11% to 1,641.58 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications operator Telefonica  and oil and gas company TotalEnergies , which rose 3.9% and 2.1%, respectively. They were followed by biopharmaceutical company Grifols  and semiconductor company Sequans Communications , which gained 1.9% and 1.3% respectively.The decliners from continental Europe were led by biotech companies BioNTech  and Evaxion , which declined 6.1% and 5% respectively. They were followed by accommodations booking company trivago  and internet browser company Opera , which were down 2.8% and 2.5% respectively.From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics  and biopharmaceutical company Amarin , which advanced 2.4% and 1.3% respectively. They were followed by pharmaceutical company AstraZeneca  and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4009","EVAX","SQNS","BK4201","LU1829250122.USD","BK4023","LU2237443895.HKD","LU2237443382.USD","PSO","AZN","BK4141","BK4505","BK4107","LU0109394709.USD","BK4535","MREO","TRVG","BK4588","TTE","BK4561","LU0889565916.HKD","BNTX","LU2129689605.HKD","LU2417539215.USD","LU2236285917.USD","LU0320765992.SGD","AMRN","AUTL","BK4548","LU2237443465.HKD","LU2129689431.USD","AFG","BK4585","GRFS","BK4115","WPP.AU","BK4139","WPP","BK4111","SLN","LU2237443549.SGD","LU2237443622.USD","BK4568","LU2129689514.USD","LU2456880835.USD","TEF","BDRX","BK4077","OPRA","BK4117"],"gpt_icon":0},{"id":"2582349248","title":"Mount Ridley grabs full control of southwest critical minerals corridor","url":"https://stock-news.laohu8.com/highlight/detail?id=2582349248","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582349248?lang=en_us&edition=fundamental","pubTime":"2025-11-12 05:54","pubTimestamp":1762898046,"startTime":"0","endTime":"0","summary":"Mount Ridley Mines has locked in full control of its Grass Patch Complex, 70km north-northeast of Esperance in WA, by expanding its tenement area to 1069 sq kms to consolidate a key critical minerals corridor.","market":"nz","thumbnail":"https://images.thewest.com.au/publication/C-20656189/306a6ef0c0897485914178ad80064794ebc4c295.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-20656189/306a6ef0c0897485914178ad80064794ebc4c295.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/mount-ridley-grabs-full-control-of-southwest-critical-minerals-corridor-c-20656189","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/mount-ridley-grabs-full-control-of-southwest-critical-minerals-corridor-c-20656189","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["MREO","BK4505","BK4139"],"gpt_icon":0},{"id":"2582092357","title":"Positive Outlook for Mereo Biopharma Group Plc Driven by Strong Clinical Progress and Strategic Initiatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2582092357","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582092357?lang=en_us&edition=fundamental","pubTime":"2025-11-11 18:05","pubTimestamp":1762855545,"startTime":"0","endTime":"0","summary":"Gil Blum, an analyst from Needham, maintained the Buy rating on Mereo Biopharma Group Plc. The associated price target remains the same with $5.00....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/positive-outlook-for-mereo-biopharma-group-plc-driven-by-strong-clinical-progress-and-strategic-initiatives-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/positive-outlook-for-mereo-biopharma-group-plc-driven-by-strong-clinical-progress-and-strategic-initiatives-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MREO","BK4505","LU2065732104.USD","PRGS","BK4139","BK4097"],"gpt_icon":0},{"id":"2582800444","title":"Mereo BioPharma Q3 Net Income USD -7.024 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2582800444","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582800444?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:12","pubTimestamp":1762809173,"startTime":"0","endTime":"0","summary":"Nov 10 (Reuters) - Mereo BioPharma Q3 operating income USD -10.015 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 10-NOV-202521:01:46.177 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nRSD1C6WrN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MREO","BK4505"],"gpt_icon":0},{"id":"2582480010","title":"Mereo BioPharma Group Q3 EPS $(0.01) Beats $(0.03) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2582480010","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582480010?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:08","pubTimestamp":1762808904,"startTime":"0","endTime":"0","summary":"Mereo BioPharma Group Q3 EPS $(0.01) Beats $(0.03) Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48766352/mereo-biopharma-group-q3-eps-0-01-beats-0-03-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Mereo BioPharma Group Q3 EPS $(0.01) Beats $(0.03) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","MREO"],"gpt_icon":0},{"id":"2582807170","title":"Press Release: Mereo BioPharma Reports Third Quarter 2025 Financial Results and Provides Corporate Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2582807170","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582807170?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:01","pubTimestamp":1762808460,"startTime":"0","endTime":"0","summary":"Data from Phase 3 Orbit and Cosmic studies of setrusumab in osteogenesis imperfecta on-track for around the end of 2025. Cash of $48.7 million as of September 30, 2025, expected to support operations into 2027. LONDON, Nov. 10, 2025  -- Mereo BioPharma Group plc  , a clinical-stage biopharmaceutical company focused on rare diseases, today announced its financial results for the third quarter ended September 30, 2025, and provided recent corporate highlights.Third Quarter 2025 Highlights, Recent Developments, and Anticipated Milestones. -- The Phase 3 Orbit and Cosmic studies, led by our partner Ultragenyx,evaluating setrusumab in pediatric and young adult patients and young. pediatric patients with OI, are progressing towards final analyses at. which time patients will have been on therapy for at least 18 months.The threshold for the Phase 3 Orbit final analysis is p<0.039 and the. threshold for the Phase 3 Cosmic final analysis is p<0.05.-- Pre-commercial efforts continue in Europe wh","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4126","OI","MREO","BK4139"],"gpt_icon":0},{"id":"2582826623","title":"Critica unlocks WA gallium in 1.8Bt rare earths resource near Mt Magnet","url":"https://stock-news.laohu8.com/highlight/detail?id=2582826623","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582826623?lang=en_us&edition=fundamental","pubTime":"2025-11-10 08:40","pubTimestamp":1762735207,"startTime":"0","endTime":"0","summary":"Critica Ltd has identified a high-value opportunity within its flagship Jupiter clay-hosted rare earth deposit in WA which shows gallium oxide as a viable by-product with a leach recovery of about 63%. ","market":"us","thumbnail":"https://images.thewest.com.au/publication/C-20635731/565b53fe775a548e523fe7fb1d800f0b576e3b09.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-20635731/565b53fe775a548e523fe7fb1d800f0b576e3b09.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/critica-unlocks-wa-gallium-in-18bt-rare-earths-resource-near-mt-magnet-c-20635731","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/critica-unlocks-wa-gallium-in-18bt-rare-earths-resource-near-mt-magnet-c-20635731","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["XJO.AU","PFS","BK4211","BK4505","BK4139","BK4195","XKO.AU","XAO.AU","MREO"],"gpt_icon":0},{"id":"2581798882","title":"Mereo BioPharma Group PLC  expected to post a loss of 2 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2581798882","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581798882?lang=en_us&edition=fundamental","pubTime":"2025-11-08 00:00","pubTimestamp":1762531209,"startTime":"0","endTime":"0","summary":"Mereo BioPharma Group PLC  expected to post a loss of2cents a share - Earnings Preview Mereo BioPharma Group PLC MREO.OQ, MREO.O is expected to  show a rise in quarterly revenue when it reports  resul","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nL8N3WJ291:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","MREO"],"gpt_icon":0},{"id":"2579188200","title":"European Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2579188200","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579188200?lang=en_us&edition=fundamental","pubTime":"2025-10-29 23:05","pubTimestamp":1761750332,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were moving higher late Wednesday morning, rising 0.34% to 1,607.10 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by medical device maker EDAP  and telecommunications company Ericsson , which climbed 16.9% and 4.1% respectively. They were followed by lender Banco Santander  and health technology company Royal Philips , which advanced 3.5% and 1.4% respectively.The decliners from continental Europe were led by biopharmaceutical company DBV Technologies  and biotech firm Evaxion , which fell 5.3% and 5.1% respectively. They were followed by semiconductor company Sequans Communications  and software firm SAP , which were down 4% and 3.2% respectively.From the UK and Ireland, the gainers were led by pharmaceutical company GSK  and mining company BHP Group , which rose 6% and 2.3% respectively. They were followed by biotech firm Trinity Biotech  and oil and gas company Shell , which were up","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4020","LU0320765646.SGD","BK4613","BK4532","BDRX","BK4082","BK7095","LU1162221912.USD","NCNA","SQNS","BK4141","BK7142","EDAP","BK7511","SHEL","BK4139","TRIB","BK4505","GSK","LU0098860793.USD","LU0300736062.USD","LU2236285917.USD","MREO","PHG","BK4207","BHP.AU","BHP","SAN.AU","BK4521","DBVT","SAP","GSK.UK","BK4201","LU0300736492.USD","SAN","BK4515","BK4168","BK4554","EVAX","BK4117","BK7507","LU1829250122.USD","AFG","BK4107","AMRN","LU0278409577.USD","ERIC","BK4591","BK4528"],"gpt_icon":0},{"id":"2578966460","title":"European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2578966460","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578966460?lang=en_us&edition=fundamental","pubTime":"2025-10-28 22:59","pubTimestamp":1761663548,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were little changed late Tuesday morning, edging 0.01% lower to 1,604.02 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm Evaxion  and telecommunications company Nokia , which rose 4.5% and 1.7% respectively. They were followed by lender Banco Santander  and semiconductor company Sequans Communications , which were up 1.3% and 0.2% respectively.The decliners from continental Europe were led by 3D printer company Materialise  and accommodations booking site trivago , which fell 2.1% and 1.8% respectively. They were followed by consumer goods giant Unilever  and pharmaceutical company Sanofi , which were down 1.6% and 1.1% respectively.From the UK and Ireland, the gainers were led by lender HSBC  and pharmaceutical company Silence Therapeutics , which advanced 4% and 3.2% respectively. They were followed by biopharmaceutical companies Akari Therapeutics  and Mereo BioPharma ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0689626769.HKD","BK4023","BK4588","LU0516423091.SGD","NCNA","BK4142","CUK","AKTX","BK4141","LU0052756011.USD","HSBA.UK","MREO","BK4585","SAN","HSHD.SI","EVAX","BK4020","SQNS","LU0348735423.USD","MTLS","00005","TRVG","ULVR.UK","BK7142","UL","LU0516422440.USD","LU0310800965.SGD","SAN.AU","UN","03143","AFG","BK4139","BK1601","SLN","BK1572","NOK","HSBC","BK4183","BDRX","BK4007","BK4077","BK4117","LU0516422952.EUR","SNY","AUTL","LU1267930227.SGD","LU0164880469.USD","BK4547","BK1610","LU0124676726.USD"],"gpt_icon":0},{"id":"2574108639","title":"European Equities Traded in the US as American Depositary Receipts Fall in Friday Trading, Down 2.8% for Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2574108639","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574108639?lang=en_us&edition=fundamental","pubTime":"2025-10-10 23:29","pubTimestamp":1760110180,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were lower late Friday morning, falling 0.8% to 1,559.9 on the S&P Europe Select ADR Index, which is down 2.8% for the week.From continental Europe, the gainers were telecommunications company Ericsson  and medical device maker EDAP TMS , which rose 1.6% and 0.7% respectively.The decliners from continental Europe were led by biotech firm Evaxion  and biopharmaceutical company DBV Technologies , which fell 5.5% and 4% respectively. They were followed by petroleum refiner Equinor  and oil and gas company Eni , which were down 2% and 1.7% respectively.From the UK and Ireland, the gainers were led by telecommunications operator Vodafone Group  and pharmaceutical company Silence Therapeutics , which advanced 1% each, followed by publishing and education company Pearson , which added 0.9%.The decliners from the UK and Ireland were led by biopharmaceutical companies Adaptimmune Therapeutics  and Biodexa Pharmaceuticals , which","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EVAX","BK4132","BK4139","BK4204","DBVT","BK4201","PSO","EDAP","BK4532","BK4020","BK4111","BK4505","BK4554","BK4585","ADAP","BK4588","VOD","E","AKTX","BK4107","BK4117","BDRX","EQNR","BK4082","BK4007","AFG","BK4591","ERIC","BK4515","SLN","MREO"],"gpt_icon":0},{"id":"2573969836","title":"European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2573969836","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573969836?lang=en_us&edition=fundamental","pubTime":"2025-10-07 23:13","pubTimestamp":1759850028,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking lower Tuesday morning, declining 0.44% to 1,591.64 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical companies DBV Technologies  and Cellectis , which climbed about 12% and 6%, respectively. They were followed by brewing company Anheuser-Busch InBev  and telecommunications company Nokia Oyj , which increased 1.9% and about 1%, respectively.The decliners from continental Europe were led by biotech firm Evaxion  and internet browser company Opera , which shed 13% and 4.4%, respectively. They were followed by biopharmaceutical company Genfit  and oil and gas company TotalEnergies , which lost 1.6% and 0.7%, respectively.From the UK and Ireland, the gainers were led by biopharmaceutical companies NuCana  and Adaptimmune Therapeutics , which advanced 11% and 6.9%, respectively. They were followed by biopharmaceutical companies Akari Therapeutics  and Amarin , ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NOK","BK4201","LU2129689605.HKD","IE00BMPRXR70.SGD","MREO","BK4207","BK4547","AKTX","LU2237443549.SGD","NCNA","BK4142","LU2129689514.USD","AMRN","BK4020","AUTL","OPRA","BK4521","BK4139","AFG","BK7119","LU2237443382.USD","GNFT","BK4585","BUD.AU","BK4158","DBVT","LU2129689431.USD","LU2237443895.HKD","ADAP","CUK","IE00BMPRXN33.USD","CLLS","BK4117","BK4007","BK4588","LU2237443465.HKD","BK4023","BK4505","LYG","LU2237443622.USD","LU2237443978.SGD","EVAX","BK4561","BUD","BK4107","TTE"],"gpt_icon":0},{"id":"2572545526","title":"European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2572545526","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572545526?lang=en_us&edition=fundamental","pubTime":"2025-10-02 23:02","pubTimestamp":1759417356,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending lower late Thursday morning, declining 0.29% to 1,585.59 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical companies DBV Technologies  and Genfit , which climbed 9.7% and 3.9%, respectively. They were followed by biopharmaceutical company argenx  and biotech firm Evaxion , which advanced 2.5% and 1.5%, respectively.The decliners from continental Europe were led by pharmaceutical company Novo Nordisk  and lender Banco Santander , which fell 1.6% and 1.5%, respectively. They were followed by lender ING Group  and pharmaceutical company Ascendis Pharma , which dropped 1.4% each.From the UK and Ireland, the gainers were led by biopharmaceutical companies Adaptimmune Therapeutics  and Biodexa Pharmaceuticals , which rose 6% and 3.7%, respectively. They were followed by biotech firm Trinity Biotech  and biopharmaceutical company Bicycle , which were up 3% and 1","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1093756168.USD","EVAX","ASND","BK4162","TRIB","BK7142","IE00B4R5TH58.HKD","BK4599","BK7505","LU0889565916.HKD","ARGX","DBVT","IE00B2B36J28.USD","LU0320765992.SGD","BK7141","LU2324357040.USD","BK4505","ING","BK4585","ADAP","BK4588","IE00BKVL7J92.USD","IE00BFTCPJ56.SGD","AKTX","BK4107","IE00BZ1G4Q59.USD","LU0109394709.USD","BDRX","NVO","IE0002141913.USD","PUK","WPP.AU","IE00BJJMRZ35.SGD","LU1093756325.SGD","GNFT","BK4007","ING.AU","IE00BJT1NW94.SGD","AFG","BK4207","BCYC","SAN.AU","SAN","LU0154236417.USD","NVO.AU","BK7104","WPP","BK4521","IE0009355771.USD","MREO"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.mereobiopharma.com","stockEarnings":[{"period":"1week","weight":0.0534},{"period":"1month","weight":0.1793},{"period":"3month","weight":0.173},{"period":"6month","weight":-0.2138},{"period":"1year","weight":-0.4182},{"period":"ytd","weight":-0.38}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. It develops Etigilimab (MPH-313), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumors. The company is also developing Navicixizumab (OMP-305B83), which has completed Phase 1b clinical trials for the treatment of the late line ovarian cancer; Acumapimod (BCT-197), a p38 MAP kinase inhibitor that is in Phase II clinical trials to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole (BGS-649), an oral aromatase inhibitor for the treatment of hypogonadotropic hypogonadism which is in Phase 2 trials. In addition, it develops rare disease product candidates, including Setrusumab (BPS-804), an antibody for the treatment of osteogenesis imperfecta; and Alvelestat (MPH-966), an oral small molecule that is in Phase II clinical trial to treat Alpha-1 anti-trypsin deficiency. The company has a license agreement with Feng Biosciences for the development and commercialization of navicixizumab; license agreement with ReproNovo for the development and commercialization of leflutrozole; licensing agreement with AstraZeneca; and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize setrusumab. Mereo BioPharma Group plc was incorporated in 2015 and is headquartered in London, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.026863},{"month":2,"riseRate":0.5,"avgChangeRate":0.038485},{"month":3,"riseRate":0,"avgChangeRate":-0.177922},{"month":4,"riseRate":0.666667,"avgChangeRate":0.141069},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.12077},{"month":6,"riseRate":0.714286,"avgChangeRate":0.399821},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.055261},{"month":8,"riseRate":0.857143,"avgChangeRate":0.105012},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.100596},{"month":10,"riseRate":0.428571,"avgChangeRate":0.068788},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.101401},{"month":12,"riseRate":0.571429,"avgChangeRate":0.135499}],"exchange":"NASDAQ","name":"Mereo Biopharma Group Plc","nameEN":"Mereo Biopharma Group Plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mereo Biopharma Group Plc(MREO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Mereo Biopharma Group Plc(MREO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Mereo Biopharma Group Plc,MREO,Mereo Biopharma Group Plc股票,Mereo Biopharma Group Plc股票老虎,Mereo Biopharma Group Plc股票老虎国际,Mereo Biopharma Group Plc行情,Mereo Biopharma Group Plc股票行情,Mereo Biopharma Group Plc股价,Mereo Biopharma Group Plc股市,Mereo Biopharma Group Plc股票价格,Mereo Biopharma Group Plc股票交易,Mereo Biopharma Group Plc股票购买,Mereo Biopharma Group Plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mereo Biopharma Group Plc(MREO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Mereo Biopharma Group Plc(MREO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction